Future investigations should aim to elucidate both the exact function of potassium channels in migraine and the reasoning behind the observed effects of blocking or opening potassium channels in the cortex or the trigeminovascular system, and the discovery or repurposing of drugs and active pharmaceutical ingredients for the treatment of migraine via their interactions with potassium channels. The gene discussed is KCNA3; the disease is migraine disorder.